CSIMarket


Laboratory Corporation Of America Holdings  (LH)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

LH's Net Cash Flow Growth by Quarter and Year

Laboratory Of America Holdings's Net Cash Flow results by quarter and year




LH Net Cash Flow (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - 653.60 -23.60 -465.80
III Quarter September 73.30 110.20 95.70 671.20
II Quarter June 72.40 233.40 -83.40 -140.30
I Quarter March 570.00 -13.90 -78.00 45.10
FY   715.70 983.30 -89.30 110.20



LH Net Cash Flow third quarter 2021 Y/Y Growth Comment
Laboratory Corporation Of America Holdings reported fall in Net Cash Flow in the third quarter by -33.48% to $ 73.30 millions, from the same quarter in 2020.
The drop in the third quarter Laboratory Corporation Of America Holdings's Net Cash Flow compares unfavorably to the Company's average Net Cash Flow rise of 24.21%.

Looking into third quarter results within Medical Laboratories industry 5 other companies have achieved higher Net Cash Flow growth. While Laboratory Corporation Of America Holdings' s Net Cash Flow drop of -33.48% ranks overall at the positon no. 436 in the third quarter.




LH Net Cash Flow ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - - - -
III Quarter September -33.48 % 15.15 % -85.74 % -
II Quarter June -68.98 % - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Laboratory Of America Holdings's third quarter 2021 Net Cash Flow $ 73.30 millions LH's Income Statement
Laboratory Of America Holdings's third quarter 2020 Net Cash Flow $ 110.20 millions Quarterly LH's Income Statement
New: More LH's historic Net Cash Flow Growth >>


LH Net Cash Flow (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - 493.1 % - -
III Quarter September 1.24 % -52.78 % - -
II Quarter June -87.3 % - - -
I Quarter March -12.79 % - - -58.78 %
FY (Year on Year)   - - - -




Net Cash Flow third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #6
Healthcare Sector #72
Overall #436

Net Cash Flow Y/Y Growth Statistics
High Average Low
221.23 % 24.21 % -83.92 %
(Dec 31 2020)   (Dec 31 2018)
Net Cash Flow third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #6
Healthcare Sector #72
Overall #436
Net Cash Flow Y/Y Growth Statistics
High Average Low
221.23 % 24.21 % -83.92 %
(Dec 31 2020)   (Dec 31 2018)

Net Cash Flow by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Laboratory Of America Holdings's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
493.1 % 21.57 % -99.77 %
(Dec 31 2020)  


LH's III. Quarter Q/Q Net Cash Flow Comment
Laboratory Corporation Of America Holdings achieved in the III. Quarter 2021 below company average Net Cash Flow growth of 1.24% quarter on quarter, to $ 73.30 millions.

III. Quarter 2021 LH's results seem to be contradictory, albeit beneath the average rise of 21.57 %, yet it demonstrates a quite recovery compare to the -52.78% in the III. Quarter 2020 Morgan Cook, Medical Laboratories industry contributor wrote.

Within Medical Laboratories industry 2 other companies have achieved higher Net Cash Flow quarter on quarter growth. While Laboratory Of America Holdings's Net Cash Flow growth quarter on quarter, overall rank is 288.


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #3
Healthcare Sector #42
Overall #288
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #3
Healthcare Sector #42
Overall #288
Net Cash Flow Q/Q Growth Statistics
High Average Low
493.1 % 21.57 % -99.77 %
(Dec 31 2020)  


LH's III. Quarter Q/Q Net Cash Flow Comment
Laboratory Corporation Of America Holdings achieved in the III. Quarter 2021 below company average Net Cash Flow growth of 1.24% quarter on quarter, to $ 73.30 millions.

Even if the III. Quarter 2021 Laboratory Of America Holdings's performance was below the ordinary of 21.57 %, this was yet promising news, as the current surge, transcends the -52.78% growth in the III. Quarter 2020

Within Medical Laboratories industry 2 other companies have achieved higher Net Cash Flow quarter on quarter growth. While Laboratory Of America Holdings's Net Cash Flow growth quarter on quarter, overall rank is 288.


Laboratory Of America Holdings's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
Cumulative Net Cash Flow 12 Months Ending $ 1,369.30 $ 1,406.20 $ 1,567.20 $ 983.30 $ 306.10
Y / Y Net Cash Flow Growth (TTM) 347.34 % 382.24 % - - -
Year on Year Net Cash Flow Growth Overall Ranking # 151 # 265 # 0 # 0 # 0
Seqeuential Net Cash Flow Change (TTM) -2.62 % -10.27 % 59.38 % 221.23 % 4.97 %
Seq. Net Cash Flow Growth (TTM) Overall Ranking # 849 # 821 # 783 # 242 # 842




Cumulative Net Cash Flow growth Comment
Assuming the Laboratory Of America Holdings's fiscal year would have ended in Sep 30 2021, Laboratory Of America Holdings would have reprted above average annual Net Cash Flow surge of 347.34% year on year, of $ 1,369 millions.
This marks a slow-down of the companys growth trends and from the 382.24% surge in Jun 30 2021.

Within the Healthcare sector 28 other companies have achieved higher trailing twelve month Net Cash Flow growth. While Total ranking has impoved so far to 151, from total ranking in previous quarter at 265.

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
221.23 %
24.21 %
-83.92 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 13
Healthcare Sector # 29
Overall # 151

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
562.73 %
176.87 %
-65.81 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 13
Sector # 177
S&P 500 # 849
Cumulative Net Cash Flow growth Comment
Assuming the Laboratory Of America Holdings's fiscal year would have ended in Sep 30 2021, Laboratory Of America Holdings would have reprted above average annual Net Cash Flow surge of 347.34% year on year, of $ 1,369 millions.
This marks a slow-down of the companys growth trends and from the 382.24% surge in Jun 30 2021.

Within the Healthcare sector 28 other companies have achieved higher trailing twelve month Net Cash Flow growth. While Total ranking has impoved so far to 151, from total ranking in previous quarter at 265.

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
221.23 %
24.21 %
-83.92 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 13
Healthcare Sector # 29
Overall # 151

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
562.73 %
176.87 %
-65.81 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 13
Sector # 177
S&P 500 # 849




Other Net Cash Flow Growth
Medical Laboratories Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
LH's Net Cash Flow Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for LH's Competitors
Net Cash Flow Growth for Laboratory Of America Holdings's Suppliers
Net Cash Flow Growth for LH's Customers

You may also want to know
LH's Annual Growth Rates LH's Profitability Ratios LH's Asset Turnover Ratio LH's Dividend Growth
LH's Roe LH's Valuation Ratios LH's Financial Strength Ratios LH's Dividend Payout Ratio
LH's Roa LH's Inventory Turnover Ratio LH's Growth Rates LH's Dividend Comparisons



Companies with similar Net Cash Flow surge for the quarter ending Sep 30 2021 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Sep 30 2021
Adapthealth Corp -2.02%$ -2.019 millions
Unity Biotechnology Inc -5.48%$ -5.484 millions
Encompass Health Corporation-7.87%$ -7.874 millions
Arbutus Biopharma Corp-8.02%$ -8.017 millions
Fulcrum Therapeutics inc -8.51%$ -8.513 millions
Panbela Therapeutics Inc -10.90%$ -10.901 millions
Nanovibronix Inc-12.08%$ -12.076 millions
Innovation Pharmaceuticals Inc -17.99%$ -17.990 millions
Intricon Corp-23.34%$ -23.344 millions
Surgepays Inc -25.53%$ -25.534 millions
Encision Inc -27.06%$ -27.061 millions
Align Technology inc -28.27%$ -28.273 millions
Quest Diagnostics Inc-30.79%$ -30.794 millions
Spero Therapeutics Inc -31.06%$ -31.057 millions
Laboratory Corporation Of America Holdings-33.48%$ -33.485 millions
Ionis Pharmaceuticals Inc -34.06%$ -34.064 millions
Themaven Inc -38.80%$ -38.797 millions
Pacira Biosciences inc -39.47%$ -39.471 millions
China Health Industries Holdings Inc -39.73%$ -39.727 millions
Albireo Pharma inc -39.74%$ -39.745 millions
Quotient Limited-40.55%$ -40.546 millions
Stryker Corp-40.81%$ -40.809 millions
Pactiv Evergreen Inc -41.19%$ -41.189 millions
Bio rad Laboratories Inc -45.33%$ -45.332 millions
Rackspace Technology Inc -50.65%$ -50.654 millions
Magenta Therapeutics Inc -53.55%$ -53.551 millions
Eli Lilly And Company-53.81%$ -53.812 millions
Coherus Biosciences inc -54.60%$ -54.601 millions
Baxter International Inc -55.51%$ -55.515 millions
Nuwellis Inc -56.02%$ -56.024 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ALPA's Profile

Stock Price

ALPA's Financials

Business Description

Fundamentals

Charts & Quotes

ALPA's News

Suppliers

ALPA's Competitors

Customers & Markets

Economic Indicators

ALPA's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071